Delivery Order SPE2DB25D3002-SPE2DB25FLRHE
- Not listed
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for MENQUADFI vials (0.5ML) with a ceiling value of $8,254.21 under a firm fixed-price contract type. The award was made on August 11, 2025, with an ultimate completion date of August 12, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This is a competitively awarded, non-set-aside delivery order issued under...
- The Defense Logistics Agency awarded a delivery order valued at $2,179.32 to AmerisourceBergen Drug Corp for MENQUADFI vials (0.5mL) on August 5, 2025, with completion scheduled for August 6, 2025. This firm fixed-price delivery order, issued without set-aside designation, reflects a competitively awarded transaction under the company's broader pharmaceutical supply relationship with DLA. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for pharmaceutical supplies, specifically MENQUADFI vial 0.5ML, with a ceiling value of $1,452.88. This delivery order utilizes a firm fixed price contract type and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The contract involves no set-aside...
- The Defense Logistics Agency awarded a delivery order valued at $7,484.58 to AmerisourceBergen Drug Corp for MENQUADFI vial 0.5ML on August 18, 2025, with an ultimate completion date of August 19, 2025. This competitively awarded, firm fixed-price contract represents a pharmaceutical supply delivery to be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract utilizes no set-aside designation and falls under a delivery order contract type,...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of MENQUADFI VIAL 0.5ML medical products. The firm-fixed-price contract has a ceiling value of $22,854.50 and a completion date of January 12, 2023. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through November 2026, which serves as the primary vehicle for...
- The Defense Logistics Agency awarded a delivery order valued at $2,179.32 to AmerisourceBergen Drug Corp for the supply of Menquadfi vials (0.5mL) to support federal medical procurement needs. This non-competitive delivery order, issued on August 18, 2025, with an ultimate completion date of August 19, 2025, represents a firm fixed-price transaction under a larger contract vehicle. The work will be performed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,452.90 to AmerisourceBergen Drug Corp for MENQUADFI VIAL 0.5ML on August 20, 2025, with an ultimate completion date of August 21, 2025. This competitively awarded, firm fixed-price contract was issued with no set-aside designation and is being performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a delivery order valued at $2,179.32 to AmerisourceBergen Drug Corp for MENQUADFI VIAL 0.5ML, a pharmaceutical product, with a completion date of August 20, 2025. This is a firm fixed-price delivery order with no set-aside designation, reflecting AmerisourceBergen's capability to compete successfully in open federal procurement. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded a delivery order valued at $15,903.80 to AmerisourceBergen Drug Corp for the supply of Menquadfi vials (0.5ML) on August 18, 2025, with an ultimate completion date of August 19, 2025. This firm fixed-price delivery order represents a non-competitive set-aside contract and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $3,656.00 to AmerisourceBergen Drug Corp for the supply of Menquadfi vials (0.5mL) on August 18, 2025, with a completion date of August 19, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is classified as a child contract under AmerisourceBergen's larger federal contract vehicle. The place of performance is listed as Conshohocken, Pennsylvania, which serves as the company's corporate...
- SPE2DB25D3002Indefinite Delivery Contract
- SPE2DB25D3002-SPE2DB25FLRHEDelivery Order
This delivery order, awarded to AmerisourceBergen Drug Corp on August 25, 2025, provides for the supply of MENQUADFI vials (0.5ML) with a ceiling value of $11,055.56. The contract represents a firm fixed-price delivery order under a non-competitive set-aside structure, with an ultimate completion date of August 26, 2025. Performance will occur at the contractor's facility in Conshohocken, Pennsylvania. This award falls under a child contract arrangement, leveraging AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Troop Support Medical division, valued at $999,999,999.00 and extending through December 2026. The Defense Logistics Agency, which serves as the funding federal agency for this award, relies on AmerisourceBergen as a major pharmaceutical distributor to fulfill critical medical supply needs across military and veteran healthcare systems. AmerisourceBergen's pharmaceutical prime vendor arrangement enables efficient delivery of a comprehensive range of products, from specialty medications to vaccines and medical supplies, supporting the Defense Health Agency, U.S. Coast Guard, and other federal healthcare entities globally. The expedited completion timeline suggests this represents a time-sensitive medical supply requirement within the broader DLA medical supply chain procurement framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.1k | 8/25/25 |